Log in

Invo Bioscience News Headlines (OTCMKTS:IVOB)

$0.26
0.00 (0.00 %)
(As of 02/23/2020 04:00 PM ET)
Today's Range
$0.21
Now: $0.26
$0.26
50-Day Range
$0.20
MA: $0.24
$0.27
52-Week Range
$0.17
Now: $0.26
$0.47
Volume2,270 shs
Average Volume38,443 shs
Market Capitalization$40.92 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.96

Headlines

Invo Bioscience (OTCMKTS IVOB) News Headlines

Source:
DateHeadline
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical AffairsINVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
finance.yahoo.com - February 13 at 9:38 AM
INVO Bioscience Receives IRB Approval to Begin Clinical Study Aimed at Expanded INVOcell LabelingINVO Bioscience Receives IRB Approval to Begin Clinical Study Aimed at Expanded INVOcell Labeling
finance.yahoo.com - February 5 at 12:30 PM
INVO Bioscience to Attend the 45th Edition of Arab Health Congress on January 27-30, 2020INVO Bioscience to Attend the 45th Edition of Arab Health Congress on January 27-30, 2020
finance.yahoo.com - January 21 at 3:33 PM
INVO Bioscience Signs Joint Venture Agreement with Medesole Healthcare and Trading Pvt Ltd to Operate Dedicated INVOcell Fertility Clinics in IndiaINVO Bioscience Signs Joint Venture Agreement with Medesole Healthcare and Trading Pvt Ltd to Operate Dedicated INVOcell Fertility Clinics in India
finance.yahoo.com - January 16 at 12:35 PM
INVO Bioscience, Inc. 2019 Q3 - Results - Earnings Call PresentationINVO Bioscience, Inc. 2019 Q3 - Results - Earnings Call Presentation
seekingalpha.com - November 22 at 7:43 PM
INVO Bioscience, Inc. (IVOB) CEO Steven Shum on Q3 2019 Results - Earnings Call TranscriptINVO Bioscience, Inc. (IVOB) CEO Steven Shum on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 21 at 7:19 PM
INVO Bioscience Reports Third Quarter 2019 Financial ResultsINVO Bioscience Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 14 at 1:36 PM
INVO Bioscience Expands its Presence in Eurasia with New Distribution Agreements to Commercialize the INVOcell In Vivo Fertilization SystemINVO Bioscience Expands its Presence in Eurasia with New Distribution Agreements to Commercialize the INVOcell In Vivo Fertilization System
finance.yahoo.com - November 12 at 9:40 AM
INVO Bioscience Enters New Distribution Agreements in Africa to Commercialize the INVOcell In Vivo Fertilization SystemINVO Bioscience Enters New Distribution Agreements in Africa to Commercialize the INVOcell In Vivo Fertilization System
finance.yahoo.com - November 7 at 1:11 PM
INVOcell Pioneers, Center for Assisted Reproduction, Named One of the 10 Best Fertility Clinics for InnovationINVOcell Pioneers, Center for Assisted Reproduction, Named One of the 10 Best Fertility Clinics for Innovation
finance.yahoo.com - November 5 at 12:55 PM
INVO Bioscience New CEO Sends Open Letter to ShareholdersINVO Bioscience New CEO Sends Open Letter to Shareholders
finance.yahoo.com - October 31 at 9:37 AM
INVO Bioscience Receives CE Mark for INVOcell Device Allowing the Company to Commercially Distribute Product in EuropeINVO Bioscience Receives CE Mark for INVOcell Device Allowing the Company to Commercially Distribute Product in Europe
finance.yahoo.com - October 24 at 2:03 PM
INVO Bioscience names Steve Shum as CEOINVO Bioscience names Steve Shum as CEO
seekingalpha.com - October 14 at 1:39 PM
INVO Bioscience Announces the Appointment of Steve Shum as Chief Executive OfficerINVO Bioscience Announces the Appointment of Steve Shum as Chief Executive Officer
finance.yahoo.com - October 14 at 8:39 AM
IVOB.PK - Invo Bioscience Inc Profile | ReutersIVOB.PK - Invo Bioscience Inc Profile | Reuters
www.reuters.com - October 8 at 1:09 PM
INVO Bioscience to Exhibit at Two Upcoming Scientific and Research ConferencesINVO Bioscience to Exhibit at Two Upcoming Scientific and Research Conferences
finance.yahoo.com - October 1 at 4:53 PM
INVO Bioscience Reports Record Second Quarter 2019 Financial Results with Revenue Increasing 498%INVO Bioscience Reports Record Second Quarter 2019 Financial Results with Revenue Increasing 498%
www.prnewswire.com - August 14 at 4:33 PM
INVO Bioscience Announces Recent Appointment of Pressly Ahammed as Director of International Business DevelopmentINVO Bioscience Announces Recent Appointment of Pressly Ahammed as Director of International Business Development
finance.yahoo.com - June 19 at 5:54 PM
INVO Biosciences INVOcell Technology Featured in IVF Exhibit at the Science Museum in LondonINVO Bioscience's INVOcell Technology Featured in IVF Exhibit at the Science Museum in London
finance.yahoo.com - June 13 at 12:35 PM
INVO Bioscience Reports First Quarter 2019 Financial ResultsINVO Bioscience Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 15 at 6:11 PM
INVO Bioscience Reports Record Fourth Quarter and Year End 2018 Financial ResultsINVO Bioscience Reports Record Fourth Quarter and Year End 2018 Financial Results
finance.yahoo.com - April 16 at 5:40 PM
"Bull Market Hopping?""Bull Market Hopping?"
finance.yahoo.com - March 27 at 10:30 AM
INVO Bioscience Launches Embryology Center in the Bay Area to Support Dedicated INVOcell Clinic Being Developed by Dr. Aimee, the "Egg Whisperer"INVO Bioscience Launches Embryology Center in the Bay Area to Support Dedicated INVOcell Clinic Being Developed by Dr. Aimee, the "Egg Whisperer"
finance.yahoo.com - March 12 at 11:20 AM
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell™ System for Use in the Treatment of InfertilityINVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell™ System for Use in the Treatment of Infertility
finance.yahoo.com - January 14 at 9:11 AM
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel